{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:03:05Z","timestamp":1790013785111,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10072-019-04156-z","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T21:11:14Z","timestamp":1576098674000},"page":"885-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Guillain-Barr\u00e9 syndrome and antecedent cytomegalovirus infection, USA 2009\u20132015"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-7555","authenticated-orcid":false,"given":"Jessica","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Sejvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana M.","family":"Lanzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"4156_CR1","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet\u00a0366:1653\u20131666"},{"key":"4156_CR2","doi-asserted-by":"crossref","unstructured":"Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barre syndrome. Lancet\u00a0 388:717\u2013727","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"4156_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123\u2013133","journal-title":"Neuroepidemiology"},{"key":"4156_CR4","doi-asserted-by":"crossref","unstructured":"Counotte MJ, Egli-Gany D, Riesen M et al (2018) Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: from systematic review to living systematic review. F1000Res 7:196","DOI":"10.12688\/f1000research.13704.1"},{"key":"4156_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archneur.1985.04060100035016","volume":"42","author":"E Beghi","year":"1985","unstructured":"Beghi E, Kurland LT, Mulder DW, Wiederholt WC (1985) Guillain-Barre syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 42:1053\u20131057","journal-title":"Arch Neurol"},{"key":"4156_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.33.5.633","volume":"33","author":"JE Kaplan","year":"1983","unstructured":"Kaplan JE, Schonberger LB, Hurwitz ES, Katona P (1983) Guillain-Barre syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology 33:633\u2013637","journal-title":"Neurology"},{"key":"4156_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000339248","volume":"39","author":"IM Shui","year":"2012","unstructured":"Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK, Vaccine Safety Datalink Research Team (2012) Guillain-Barre syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology 39:109\u2013115","journal-title":"Neuroepidemiology"},{"key":"4156_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1017\/S0950268818001802","volume":"146","author":"AL Halpin","year":"2018","unstructured":"Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE (2018) Post-Campylobacter Guillain Barre Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect 146:1740\u20131745","journal-title":"Epidemiol Infect"},{"key":"4156_CR9","doi-asserted-by":"crossref","unstructured":"Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Rapha\u00ebl JC, Durand MC, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-Ville M, Gaillard JL, Gault E (2011) Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 52:837\u2013844","DOI":"10.1093\/cid\/cir074"},{"key":"4156_CR10","unstructured":"Quint JB. Health research data for the real world: the MarketScan databases. Truven Health Analytics White Paper. [online]. Available at: https:\/\/marketscan.truvenhealth.com\/marketscanuniversity\/publications\/2015%20MarketScan%20white%20paper.pdf"},{"key":"4156_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpeds.2016.05.018","volume":"175","author":"AJ Shoffstall","year":"2016","unstructured":"Shoffstall AJ, Gaebler JA, Kreher NC, Niecko T, Douglas D, Strong TV, Miller JL, Stafford DE, Butler MG (2016) The high direct medical costs of Prader-Willi syndrome. J Pediatr 175:137\u2013143","journal-title":"J Pediatr"},{"key":"4156_CR12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2105\/AJPH.2011.300510","volume":"102","author":"DR Burwen","year":"2012","unstructured":"Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, Garcia B, Markatou M, Forshee RA, Izurieta HS, Ball R, Safety Surveillance Working Group (2012) Surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2009-2010. Am J Public Health 102:1921\u20131927","journal-title":"Am J Public Health"},{"key":"4156_CR13","unstructured":"Inokuchi H, Yasunaga H, Nakahara Y, Horiguchi H, Ogata N, Fujitani J, Matsuda S, Fushimi K, Haga N (2014) Effect of rehabilitation on mortality of patients with Guillain-Barre syndrome: a propensity-matched analysis using nationwide database. Eur J Phys Rehab Med 50:439\u2013446"},{"key":"4156_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2017.04.006","volume":"377","author":"JL Salinas","year":"2017","unstructured":"Salinas JL, Major CG, Pastula DM, Dirlikov E, Styczynski A, Luciano CA, Wojna V, Sharp TM, Sejvar JJ, Rivera-Garcia B (2017) Incidence and clinical characteristics of Guillain-Barre syndrome before the introduction of Zika virus in Puerto Rico. J Neurol Sci 377:102\u2013106","journal-title":"J Neurol Sci"},{"key":"4156_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150\u2013163","journal-title":"Neuroepidemiology"},{"key":"4156_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/ane.13000","volume":"138","author":"B Hafsteinsdottir","year":"2018","unstructured":"Hafsteinsdottir B, Olafsson E, Jakobsson F (2018) Incidence and outcome of Guillain-Barre syndrome in Iceland: a population-based study. Acta Neurol Scand 138:454\u2013458","journal-title":"Acta Neurol Scand"},{"key":"4156_CR17","doi-asserted-by":"crossref","unstructured":"Al-Hakem H, Sindrup SH, Andersen H et al (2018) Guillain-Barre syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol","DOI":"10.1007\/s00415-018-9151-x"},{"key":"4156_CR18","doi-asserted-by":"crossref","unstructured":"Styczynski AR, Malta J, Krow-Lucal ER et al (2017) Increased rates of Guillain-Barre syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Negl Trop Dis 11:e0005869","DOI":"10.1371\/journal.pntd.0005869"},{"issue":"Suppl 2","key":"4156_CR19","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1086\/513793","volume":"176","author":"RA Hughes","year":"1997","unstructured":"Hughes RA, Rees JH (1997) Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 176(Suppl 2):S92\u2013S98","journal-title":"J Infect Dis"},{"key":"4156_CR20","doi-asserted-by":"crossref","unstructured":"Granieri E, Andreasi NG, De Martin P et al (2019) Incidence study of Guillain-Barre syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up. Neurol Sci 40:603\u2013609","DOI":"10.1007\/s10072-018-3688-4"},{"key":"4156_CR21","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1093\/infdis\/175.Supplement_1.S151","volume":"175 Suppl 1","author":"DR Prevots","year":"1997","unstructured":"Prevots DR, Sutter RW (1997) Assessment of Guillain-Barre syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 175 Suppl 1:S151\u2013S155","journal-title":"J Infect Dis"},{"key":"4156_CR22","doi-asserted-by":"crossref","unstructured":"Flachenecker P (2007) Autonomic dysfunction in Guillain-Barre syndrome and multiple sclerosis. J Neurol 254 Suppl 2:Ii96\u2013I101","DOI":"10.1007\/s00415-007-2024-3"},{"key":"4156_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s004150050506","volume":"246","author":"G Pfeiffer","year":"1999","unstructured":"Pfeiffer G, Schiller B, Kruse J, Netzer J (1999) Indicators of dysautonomia in severe Guillain-Barre syndrome. J Neurol 246:1015\u20131022","journal-title":"J Neurol"},{"key":"4156_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","volume":"51","author":"JB Winer","year":"1988","unstructured":"Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51:613\u2013618","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4156_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes RA, Hadden RD, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 100:74\u201397","journal-title":"J Neuroimmunol"},{"key":"4156_CR26","doi-asserted-by":"crossref","unstructured":"Visser LH, van der Meche FG, Meulstee J et al (1996) Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 47:668\u2013673","DOI":"10.1212\/WNL.47.3.668"},{"key":"4156_CR27","unstructured":"Stagno SBW (2006) Cytomegalovirus. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds) Infectious disease of the fetus and newborn infant. WB Saunders Co, Philadelphia, pp 389\u2013424"},{"key":"4156_CR28","doi-asserted-by":"crossref","unstructured":"Bogliun G, Beghi E (2002) Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barre syndrome. Neurol Sci 23:113\u2013117","DOI":"10.1007\/s100720200036"},{"key":"4156_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.410300418","volume":"30","author":"TJ Koobatian","year":"1991","unstructured":"Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL (1991) The use of hospital discharge data for public health surveillance of Guillain-Barre syndrome. Ann Neurol 30:618\u2013621","journal-title":"Ann Neurol"},{"key":"4156_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, Brighton Collaboration GBS Working Group (2011) Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29:599\u2013612","journal-title":"Vaccine"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04156-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04156-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04156-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:57:13Z","timestamp":1607565433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04156-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04156-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This analysis only included deidentified data; it was therefore deemed by the Centers for Disease Control and Prevention (CDC) not to be human subject research and it did not require CDC\u2019s Institutional Review Board approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, US Department of Health and Human Services.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}